Gaze Mapping Biomarkers (GMBs)
Gaze Mapping Biomarkers (GMBs) are distinct from EMBs as they quantitatively measure aspects of cognition by analyzing gaze patterns that are produced while individuals perform short visual tasks. GMBs will incorporate, for instance, measures of sustained attention, attention-switching, processing speed, working memory and response inhibition. GMBs can also be used by healthcare professionals to track disease progression, monitor treatment effects and assist with diagnoses.